Future of Lab Conference - Medlab Middle East Congress

Future of Lab Conference (Online)

4.75 CME Credits

Live edition

5 - 8 February 2024

Dubai World Trade Centre


22 Jan - 22 Feb 2024


Future of Lab Conference (Online)

4.75 CME Credits



The Future of lab is digitalisation, automation and connectivity.   

This online-only conference track at Medlab is tailored to feature a balanced discussion, learning and interaction on cutting-edge research and technology driving the advances in medical laboratory research and practices.  It aims to present collaborative innovative tools that are usable and applicable to daily lab operations, improving the role of every lab pathologist, technologist and technician. 

Key topics:


  • The role of diagnostics in behavior change  
  • Trends & growth opportunities in SMART labs (IVD) market
  • OMICs clinical applications
  • Therapeutics of rare diseases using autologous stem cell therapy

Benefits of attending:


  • Review the role of digitalisation and AI in the medical laboratory for enhanced diagnostic efficacy 
  • Appraise the potential and pitfalls of emerging technologies 
  • Identify the challenges and potential for the use of stem cells in therapeutic treatment  
  • Discuss integration of multiple omics technologies including genomics, transcriptomics, proteomics, and metabolomics 


Activity Director:


  • Dr Ziad Peerwani, Medical Director, Cleveland Clinic Laboratories, Pathology & Laboratory Medicine Institute-PLMI, Cleveland Clinic, Cleveland, Ohio, USA 



  • Amartya Bose, Industry Analyst, Healthcare and Lifesciences, Frost & Sullivan, Dubai, UAE
  • A/Prof Amy Jennison, Acting Managing Scientist, Public and Environmental Health; Chief Scientist Public Health Microbiology & Queensland Public Health and Infectious diseases Reference Genomics (Q-PHIRE Genomics) & Public and Environmental Health Research Coordinator Forensic and Scientific Services Prevention Division, Queensland Health, Queensland, Australia 
  • Dr Brad Karon, Professor, Laboratory Medicine and Pathology; Dean, Mayo Clinic School of Health Sciences (MCSHS), Mayo Clinic, Rochester, Minnesota, USA
  • Dr Doaa Alhaboby, Health and Innovation Director, Unilabs ME, Dubai, UAE
  • Maha El Naofal, Genomics Laboratory Supervisor, Al Jalila Children's Specialty Hospital, Dubai, UAE 
  • Dr Rick Kamps, Head Research Engineer, Department of Toxicogenomics, Maastricht University, Maastricht, The Netherlands
  • Dr Sally Mahmoud, Lab Director and Clinical Pathologist, Biogenix Labs, G42 Healthcare, Abu Dhabi, UAE 
  • Dr Samer Albahra, Director, Research and Development, Center for Artificial Intelligence & Data Science, Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA